首页> 外文期刊>The pharmaceutical journal >Reducing antipsychotics in dementia
【24h】

Reducing antipsychotics in dementia

机译:减少痴呆症中的抗精神病药

获取原文
获取原文并翻译 | 示例
           

摘要

THE prescribing of low-dose antipsychotics for challenging behaviour for people with dementia gained prominence following media attention and the publication of the Banerjee report in 2006. The report identified that there are an estimated 180,000 people with dementia on antipsychotic drugs. However, in only about one-third of cases were the drugs beneficial. There were 1,800 excess deaths per year as a result of their prescription and up to 1,620 cerebrovascular events. The report suggests that, if support were available to provide alternative methods of managing behavioural problems, prescribing of antipsychotics could be reduced by two thirds in people with dementia.
机译:在媒体关注并于2006年发布Banerjee报告后,低剂量抗精神病药对痴呆症患者具有挑战性行为的处方受到关注。该报告确定,估计有18万抗精神病药物痴呆症患者。但是,只有约三分之一的病例对药物有益。由于他们的处方和每年多达1,620例脑血管事件,导致1800例额外死亡。该报告建议,如果能够获得支持以提供其他解决行为问题方法的支持,则痴呆症患者的抗精神病药处方可减少三分之二。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号